5-9 | Medical organisation warns that outbreak is not over yet and cross-border surveillance must continue After 42 days with no recorded cases of Ebola, Liberia has been declared Ebola-free by the World Health Organization (WHO) – news which has been welcomed by Médecins Sans Frontières/Doctors Without Borders (MSF).
MSF releases a critical analysis of the global Ebola response one year into the deadliest outbreak in history
3-23 | Médecins Sans Frontières (MSF) today releases a critical analysis of the Ebola epidemic in west Africa over the past year, revealing the shortcomings of the global response to the crisis and warning that the outbreak, despite an overall decline in cases, is not yet over. The report, Pushed to the limit and beyond, is based on interviews with dozens of MSF staff involved in the organisation’s Ebola intervention.
2-24 | Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is ineffective for patients with high viral loads who are very sick with the disease. The ongoing clinical trial, led by French research institute INSERM, was launched on 17 December 2014 at an Ebola treatment centre run by Médecins Sans Frontières/Doctors Without Borders in Guéckédou, Guinea, where the current outbreak started.
2-12 | Ebola survivor Amie Subah tells her story: I contracted Ebola through midwifing a pregnant woman. Unfortunately, the woman was infected and she died of the virus as well as her baby. Eight staff members from the clinic where I worked, including myself, got infected through that delivery. Only two of us survived after being admitted at the Ebola management center. I returned home, but no one would welcome me back into the community.
2-3 | A trial of the experimental Ebola drug brincidofovir in Liberia has been halted due to a significant drop in the number of new Ebola cases, coupled with the 30 January announcement by the drug’s manufacturer that it would no longer participate in the trial. Led by Oxford University, the trial into a potential treatment for the disease was launched in early January in an Ebola management centre run by Médecins Sans Frontières/Doctors Without Borders (MSF) in the Liberian capital Monr